Plummer-Vinson Syndrome: Iron Deficiency, Esophageal Web, and Postcricoid Cancer Surveillance

Plummer-Vinson Syndrome: Iron Deficiency, Esophageal Web, and Postcricoid Cancer Surveillance

A clinician’s playbook for the rare but pathognomonic triad — iron deficiency anemia plus dysphagia plus cervical esophageal web (also called Paterson-Brown-Kelly syndrome) — recognizing the postmenopausal female phenotype, confirming with barium swallow and endoscopy, treating with iron repletion plus endoscopic web dilation, and committing to lifelong postcricoid carcinoma surveillance.

Executive Summary

Plummer-Vinson syndrome (PVS; also Paterson-Brown-Kelly syndrome in the British literature; also sideropenic dysphagia) is a rare clinical entity defined by the classic triad of iron deficiency anemia + dysphagia + cervical (postcricoid) esophageal web. The disease was first described in 1912 and was once common in northern European populations (particularly Scandinavia and the UK) where dietary iron deficiency was prevalent, but has become rare in modern high-resource settings — paralleling the broad decline of severe nutritional iron deficiency. Globally, PVS persists in regions with high background rates of iron deficiency. The disease characteristically affects postmenopausal women, typically in the 4th–7th decade, with a female-to-male ratio of approximately 5:1. The pathogenesis is incompletely understood but appears to involve chronic iron deficiency producing atrophy of pharyngeal and upper esophageal mucosa with development of a thin mucosal membrane (web) at the postcricoid junction of the cervical esophagus. The web is a true mucosal membrane — usually anterior, eccentric, 1–2 mm thick — that partially obstructs the esophageal lumen at the cricopharyngeal level. Clinical features: intermittent dysphagia (especially for solids), often present for years and minimized by the patient; classic iron deficiency stigmata including pale conjunctivae, koilonychia (spoon-shaped nails), angular cheilitis, atrophic glossitis with smooth tongue, dysgeusia; sometimes splenomegaly; and the laboratory features of iron deficiency anemia (microcytic hypochromic anemia, low ferritin, low transferrin saturation, elevated TIBC). Diagnosis combines the clinical triad with barium swallow demonstrating the cervical web as a thin shelf-like filling defect, endoscopy with direct visualization (and possibly biopsy to exclude alternative pathology), and laboratory confirmation of iron deficiency. The most clinically important feature is the established association with postcricoid and proximal esophageal squamous cell carcinoma — PVS confers approximately 4–16% lifetime risk of esophageal SCC, an order of magnitude above general population — mandating lifelong endoscopic surveillance even after symptomatic resolution. Treatment is two-pronged. Iron repletion — oral ferrous sulfate 325 mg PO daily-to-TID, or IV iron when oral intolerance or malabsorption — restores hematologic status and frequently resolves dysphagia within weeks-to-months as mucosal atrophy reverses. Endoscopic web dilation — through-the-scope balloon dilation or Savary-Gilliard bougie — provides immediate mechanical relief of dysphagia for patients whose symptoms do not resolve with iron repletion alone or whose web is severely obstructive. The web may also be incised endoscopically. Recurrence after dilation is uncommon when iron deficiency is durably corrected. Underlying cause workup for the iron deficiency itself is essential — this includes upper and lower endoscopy in nearly all PVS patients given the cancer risk and to identify GI sources of iron loss. Lifelong postcricoid cancer surveillance — endoscopy every 1–3 years depending on individual risk — is the surveillance commitment that defines modern PVS care.

Triad
Iron deficiency + dysphagia + cervical esophageal web
5:1
Female predominance; postmenopausal 4-7th decade typical
Postcricoid
Cervical esophageal location of web (cricopharyngeal level)
~4–16%
Lifetime esophageal SCC risk — lifelong surveillance

S1. Pathophysiology — Iron Deficiency, Mucosal Atrophy, Web Formation

The Iron Deficiency Connection

The central mechanistic feature of PVS is chronic iron deficiency producing trophic mucosal changes in the upper aerodigestive tract. Iron is required for normal cellular replication and for iron-dependent enzyme systems (particularly cytochrome oxidase and ribonucleotide reductase) that are crucial for rapidly dividing epithelial cells. Tissues with high cellular turnover — including the tongue, pharynx, and upper esophagus — are particularly vulnerable to iron-deficient mucosal atrophy. Over years of chronic iron deficiency, mucosal atrophy in the postcricoid region progresses to development of a thin mucosal membrane (web) that partially obstructs the esophageal lumen.

Why the Postcricoid Location?

The postcricoid esophagus — at the cricopharyngeal level, just below the upper esophageal sphincter — is the characteristic web location. Several anatomic and physiologic factors converge here:

Postcricoid Esophageal Web — Sagittal AnatomyLabeled side-view of the pharynx and cervical esophagus locating the Plummer-Vinson web at the postcricoid cricopharyngeal level just below the upper esophageal sphincter, with an inset showing the anterior eccentric mucosal membrane partially obstructing the lumen.Postcricoid Web — Sagittal Upper Aerodigestive AnatomyTongueEpiglottisLarynxCricoid cartilageCricopharyngeus (UES)WEB — anterior eccentricpostcricoid, cricopharyngeal levelCervical esophagusInset — Luminal Cross-Sectionanterior wallresidual lumenThin mucosal membrane, 1–2 mmpartially obstructs the esophageal lumenWhy here: squamous transition zone,cricopharyngeal mechanical stress,natural narrowing + watershed perfusionWeb sits just below the UES — easily missed on rapid endoscope passage; inspect postcricoid level on withdrawal.
  • Transition zone from stratified squamous epithelium with high cellular turnover to the esophageal proper
  • Mechanical stress from cricopharyngeal contraction during swallowing — particularly susceptible to wear when mucosa is atrophic
  • Anatomic narrowing at this level naturally — small membranous additions produce disproportionate luminal compromise
  • Watershed perfusion in some anatomic descriptions — making this area metabolically vulnerable

Postmenopausal Female Predominance

The disease’s striking predilection for postmenopausal women reflects several converging factors:

  • Prolonged menstrual iron loss over reproductive years producing cumulative iron deficit
  • Dietary factors — historically, post-WW1 Northern European female populations had high rates of dietary iron deficiency
  • Pregnancy-related iron depletion in multiparous women
  • Postmenopausal age reflects the time required for chronic iron deficiency to produce trophic mucosal changes
  • Possibly hormonal or genetic factors — incompletely understood

Esophageal Cancer Association

The most clinically consequential aspect of PVS pathophysiology is the established association with squamous cell carcinoma of the postcricoid esophagus, hypopharynx, and oral cavity. Mechanisms underlying this elevated cancer risk:

  • Chronic iron deficiency itself may be carcinogenic to upper aerodigestive mucosa through impaired DNA repair and epithelial proliferation control
  • Chronic mucosal inflammation and regeneration at the web site provides a substrate for malignant transformation
  • Mechanical irritation from impacted food at the web
  • Lifetime risk of esophageal SCC in PVS patients is estimated at 4–16% in published series — substantially elevated above general population baseline of approximately 0.5% — and is the rationale for lifelong endoscopic surveillance even after symptomatic resolution
Plummer-Vinson Syndrome Pathophysiology and Cancer Risk Four-panel infographic showing chronic iron deficiency producing upper aerodigestive mucosal atrophy with web formation, postcricoid esophageal anatomy with web location at cricopharyngeal level, classic triad of iron deficiency anemia plus dysphagia plus cervical web with stigmata, and 4-16 percent lifetime esophageal SCC risk demanding lifelong endoscopic surveillance. Plummer-Vinson — Iron Deficit to Mucosal Web to Cancer Risk A. Iron Deficiency → Mucosal Atrophy Chronic iron deficiency (menstrual / dietary) Impaired epithelial turnover (Fe-dependent enzymes) Pharyngeal + upper esophageal mucosal atrophy Cervical esophageal web formation B. Postcricoid Web Anatomy Esophagus UES cricopharyngeus WEB postcricoid esophagus Anterior eccentric mucosal membrane, 1–2 mm thick C. Classic Triad + Stigmata 1. Iron deficiency anemia 2. Dysphagia (solids, intermittent) 3. Cervical esophageal web Examination stigmata: • Koilonychia (spoon-shaped nails) • Atrophic glossitis (smooth tongue) • Angular cheilitis + pale conjunctivae D. Esophageal SCC Risk + Surveillance Lifetime esophageal SCC risk ~4–16% (vs population ~0.5%) Mechanism: chronic mucosal injury + impaired epithelial control + mechanical stress Lifelong EGD surveillance every 1–3 years Even after symptomatic resolution

S2. Diagnosis — Triad Recognition, Barium Swallow, Endoscopy

Clinical Triad and Stigmata

The classic triad is the diagnostic anchor, complemented by characteristic iron-deficiency stigmata visible on examination:

  • Iron deficiency anemia — microcytic hypochromic anemia; low ferritin; low transferrin saturation; elevated TIBC; elevated soluble transferrin receptor
  • Dysphagia — particularly for solids; often intermittent and present for years before evaluation; patients frequently minimize symptoms or modify diet to avoid offending textures
  • Cervical (postcricoid) esophageal web — confirmed on barium swallow or direct endoscopic visualization
  • Koilonychia (spoon-shaped nails) — chronic iron deficiency stigma; finger and toenails affected
  • Atrophic glossitis — smooth red tongue with loss of papillae; burning sensation; dysgeusia
  • Angular cheilitis — painful fissures at the corners of the mouth
  • Pale conjunctivae and pallor — anemia stigmata
  • Splenomegaly — uncommon but reported in chronic untreated cases
  • Brittle hair and skin changes
  • Pica — particularly ice (pagophagia); helpful historical clue

Laboratory Confirmation of Iron Deficiency

TestFindingNotes
CBC with smearMicrocytic hypochromic anemia; pencil cells; anisocytosis; thrombocytosis commonMCV often <70 fL; RDW elevated
FerritinLow (<30 ng/mL diagnostic of iron deficiency; <100 ng/mL with inflammation may indicate)Most specific single test; acute phase reactant — may be falsely normal with concurrent inflammation
Transferrin saturationLow (<20%)Reflects iron available for erythropoiesis
TIBCElevatedCompensatory upregulation
Soluble transferrin receptor (sTfR)ElevatedUseful when ferritin equivocal due to inflammation
Reticulocyte countLow or inappropriately low for degree of anemiaReflects iron-limited erythropoiesis

Imaging — Barium Swallow

Barium swallow with attention to the cervical esophagus is the traditional imaging modality. Web findings:

Plummer-Vinson Diagnostic PathwayBranching decision tree: iron deficiency anemia plus dysphagia leads to confirmatory iron studies, then barium swallow and endoscopy to locate the postcricoid web, with mandatory biopsy separating a benign web diagnosis from esophageal squamous cell carcinoma.Diagnostic Pathway — Triad Confirmation & Cancer ExclusionIron deficiency anemia + dysphagia± koilonychia, glossitis, cheilitisConfirm iron deficiency (labs)Ferritin <30 ng/mL · TSAT <20% · TIBC highMicrocytic hypochromic, MCV often <70 fLImage the cervical esophagus?Barium swallow (lateral) + EGDBarium swallowThin shelf-like filling defect,anterior eccentric, postcricoidLateral/oblique view most sensitiveEndoscopy (EGD)Inspect cricopharyngeal levelon withdrawal — web easily missedNBI / chromoendoscopy for dysplasiaBiopsy web + surrounding mucosaMANDATORY cancer exclusionno dysplasiamass / dysplasiaPlummer-Vinson syndromeIron repletion + dilation;source workup + surveillancePostcricoid SCCUrgent ENT + oncology referral;stage & treat as head/neck cancerParallel: source workup for the iron deficiency itself
  • Thin shelf-like filling defect at the postcricoid level — typically anterior, eccentric, 1–2 mm thick
  • Lateral or oblique projection often shows the web most clearly; AP projection may miss it
  • Standing or sitting position often required; web can be missed on supine imaging
  • Video swallow with rapid imaging through the cervical esophagus is the most sensitive technique
  • Functional features: web may produce upstream barium pooling, slowed cervical transit, or distention proximal to the web

Endoscopy

Upper endoscopy (EGD) is essential for both diagnosis and cancer exclusion:

  • Direct visualization of the web at the postcricoid level — careful attention required as the web is just below the upper esophageal sphincter and easily missed on rapid endoscope passage
  • Biopsy of the web and surrounding mucosa to exclude malignancy — particularly important given the elevated SCC risk
  • Inspection of pharynx, hypopharynx, and entire esophagus for synchronous malignancy or other pathology
  • Endoscopic dilation can be performed during the diagnostic procedure if web is confirmed and dilation is appropriate
  • Narrow-band imaging or chromoendoscopy may enhance detection of early dysplastic changes

Iron Deficiency Source Workup

Every PVS patient requires workup for the underlying cause of iron deficiency itself:

  • Upper and lower endoscopy for occult GI bleeding sources (peptic ulcer, vascular ectasia, gastric or colonic cancer)
  • Celiac serology (anti-tissue transglutaminase IgA, anti-deamidated gliadin) — celiac disease can produce iron deficiency through malabsorption
  • H. pylori testing — may contribute to iron deficiency through bleeding or altered absorption
  • Gynecologic evaluation in still-menstruating women
  • Dietary assessment — vegetarian, vegan, or otherwise restricted diets
  • Bariatric surgery history
  • Hepatic and renal function

Cancer Exclusion at Diagnosis Is Mandatory

Approximately 4–16% of PVS patients have or develop esophageal SCC. Every newly diagnosed PVS patient requires careful endoscopic inspection of the postcricoid region, hypopharynx, and entire esophagus, with biopsy of any suspicious lesion and of the web itself. Symptoms that should specifically raise cancer concern include sudden worsening of dysphagia, weight loss, odynophagia, or hoarseness — these warrant urgent ENT and gastroenterology evaluation, not attribution to the underlying web.

S3. Treatment — Iron Repletion, Endoscopic Dilation, Source Workup

Iron Repletion

Iron repletion is the foundational therapy. Hematologic correction frequently produces resolution of dysphagia within weeks-to-months as mucosal atrophy reverses, without need for any other intervention in some patients.

PVS Treatment Ladder and Surveillance TimelineAscending treatment ladder from oral iron through intravenous iron, endoscopic balloon or bougie dilation, and endoscopic incision for fibrotic webs, paired with an outcome timeline showing hemoglobin normalization, ferritin repletion, and lifelong cancer surveillance every one to three years.Treatment Escalation & Lifelong Outcome TimelineEscalation ladder (step up if insufficient)1 · Oral ferrous sulfate325 mg PO daily–TID (65 mg elemental) + vitamin C 250 mg2 · Intravenous ironOral intolerance / malabsorption / rapid repletion needed3 · Endoscopic dilationTTS balloon 12–20 mm or Savary-Gilliard bougie4 · Endoscopic incisionNeedle-knife / APC for thick fibrotic webOutcome timelineWeek 0 — Start iron ± dilationDilation gives immediate mechanical reliefWeek 8–12 — Hgb & MCV normalizeReassess for dilation if dysphagia persistsMonth 6 — Ferritin >50 ng/mLContinue iron ≥6 mo after Hgb normalizesMonth 6–12 — Confirm web resolutionFollow-up EGD; dilate if web persistsLifelong — Cancer surveillanceEndoscopy every 1–3 years indefinitelyPostcricoid, hypopharynx, oral cavity4–16% lifetime SCC risk — biopsy any lesionTobacco + alcohol cessation each visitContinues beyond symptom & web resolutionParallel mandatory: source workup• Bidirectional endoscopy (EGD + colonoscopy)• Celiac serology; H. pylori testing & eradication• Gynecologic eval if still menstruating• Dietary counseling; treat identified bleeding sourcePrevents recurrent deficiency after repletionRecurrence after dilation is uncommon when iron deficiency is durably corrected and its underlying cause is treated.
RouteRegimenNotes
Oral ferrous sulfate325 mg PO daily-to-TID (65 mg elemental iron per tablet)First-line; absorption enhanced by vitamin C 250 mg; take on empty stomach if tolerated; GI side effects common
Alternative oral iron formulationsFerrous gluconate 325 mg, ferrous fumarate 325 mg, iron polysaccharide complexesComparable efficacy; may have different tolerability profiles
Alternate-day oral dosing325 mg every other day OR every third dayEmerging evidence suggests less hepcidin-mediated block of absorption with alternate-day dosing; may be more effective and better tolerated
Intravenous ironIron sucrose, ferric carboxymaltose, ferumoxytol, iron isomaltoside per institutional protocolFor oral intolerance, malabsorption (celiac, post-bariatric), severe anemia requiring rapid repletion, or failure of oral therapy
TransfusionPRBC as needed for symptomatic anemia or hemodynamic instabilityBridging only — does not address underlying deficiency

Endoscopic Web Dilation

Endoscopic dilation provides immediate mechanical relief of dysphagia. Indications:

  • Severely symptomatic dysphagia at presentation requiring rapid relief
  • Failure of iron repletion alone to resolve dysphagia at 8–12 weeks
  • Thick or fibrotic web unlikely to resolve with iron alone
  • Recurrent or persistent symptoms despite hematologic correction
TechniqueNotes
Through-the-scope (TTS) balloon dilationMost common modern approach; balloon sized 12–20 mm depending on luminal diameter; gradual stepwise dilation
Savary-Gilliard bougie dilationTraditional rigid dilator over guidewire; precise sizing; may be preferred when ruling out distal pathology with concurrent dilation
Endoscopic incision / electrocauteryDirect web disruption with needle knife or argon plasma coagulation; option for thick fibrotic webs
Esophageal stentNot standard for PVS; reserved for complications

Dilation outcomes: Web rupture during dilation produces immediate symptomatic relief. Recurrence after dilation is uncommon when iron deficiency is durably corrected. Complications are uncommon but include esophageal perforation (rare with careful technique) and bleeding.

Source Workup for Iron Deficiency

Beyond treating the iron deficiency, identifying and addressing the underlying cause is essential. The workup parallels standard iron deficiency anemia evaluation but is even more important in PVS given the cancer association and chronicity:

  • Bidirectional endoscopy (EGD + colonoscopy) for occult GI bleeding sources
  • Celiac serology and small bowel biopsies if positive
  • H. pylori eradication if positive
  • Gynecologic evaluation for menstrual or uterine pathology in still-menstruating women
  • Dietary counseling for chronic dietary iron insufficiency
  • Treatment of any identified bleeding source

Treatment Pearls

  • Iron repletion alone often resolves dysphagia within weeks to months as mucosal atrophy reverses — a trial of iron before committing to dilation is reasonable in mild-to-moderate symptoms.
  • Dilation provides immediate relief when iron alone is insufficient or when symptoms are severe — both approaches can be combined.
  • Source workup for the iron deficiency is mandatory — bidirectional endoscopy plus celiac serology plus H. pylori — and identifies treatable contributors that prevent recurrence.
  • Plan lifelong cancer surveillance at the first visit — endoscopy every 1–3 years per individual risk, indefinitely, regardless of symptomatic resolution.
  • Counsel about iron repletion duration — typically 6 months of therapy after hemoglobin normalization to replenish stores, with ongoing monitoring thereafter.
  • Tobacco and alcohol counseling — both substantially synergize the SCC risk in PVS; cessation is part of cancer prevention.

S4. Monitoring — Hematologic Response, Web Resolution, Cancer Surveillance

Surveillance Schedule

PhaseHematologicSymptom / EndoscopyCancer Surveillance
Active repletion (0–6 months)CBC, ferritin every 4 weeks; transferrin saturation monthlyDysphagia assessment monthly; reassess for dilation if no improvement at 8–12 weeksDiagnostic endoscopy at presentation; repeat at 6–12 months
Stabilization (6–12 months)Quarterly CBC, ferritinSymptom assessment quarterlyEndoscopy at 12 months
Long-term maintenance (>12 months)Annual CBC, ferritin; continue iron repletion as needed to maintain ferritin >50 ng/mLAnnual symptom review; symptom-driven endoscopy if dysphagia recursSurveillance endoscopy every 1–3 years indefinitely; tobacco/alcohol counseling at each visit

Hematologic Response Targets

  • Hemoglobin: normalization within 8–12 weeks of adequate iron therapy
  • MCV: normalization typically by 12 weeks
  • Ferritin: target >50 ng/mL; ideally >100 ng/mL for adequate stores
  • Transferrin saturation: target >20%
  • Continue iron repletion for at least 6 months after hemoglobin normalization to replenish stores
  • Maintenance iron supplementation may be indicated indefinitely if underlying cause persists (menstrual loss, malabsorption)

Web Resolution Assessment

  • Dysphagia improvement is the primary clinical endpoint — many patients note resolution within weeks-to-months of iron repletion
  • Follow-up endoscopy at 6–12 months can confirm web resolution or persistence; web persistence with continued symptoms warrants dilation
  • Even after dysphagia resolves, lifelong endoscopic surveillance for esophageal cancer continues — the cancer risk persists beyond symptomatic resolution

Cancer Surveillance

Lifelong endoscopic surveillance is the defining commitment of modern PVS care:

  • Endoscopy every 1–3 years depending on individual risk factors (web persistence, tobacco/alcohol use, dysplastic changes on prior endoscopy)
  • Careful inspection of the postcricoid region, hypopharynx, and oral cavity — locations of elevated SCC risk
  • Biopsy of any suspicious lesion — irregular mucosa, ulceration, nodularity, white plaques
  • Narrow-band imaging or chromoendoscopy may enhance detection
  • ENT evaluation with laryngoscopy considered periodically given upper aerodigestive cancer risk
  • Tobacco and alcohol cessation counseling at every visit — both substantially increase synergistic risk

Pearl — New Dysphagia in Stable PVS = Cancer Until Proven Otherwise

In a patient with established PVS whose dysphagia previously resolved with iron repletion or dilation, new or worsening dysphagia should be treated as potential esophageal cancer until urgent endoscopy demonstrates otherwise. The 4–16% lifetime cancer risk concentrates at the postcricoid region, and early dysphagia change is the typical presenting symptom. Empirical attribution to recurrent web or reflux delays cancer diagnosis.

Pitfall — Stopping Surveillance When Symptoms Resolve

Symptom resolution after iron repletion can produce a false sense that the disease is “cured” and surveillance is unnecessary. This is wrong. The esophageal cancer risk persists beyond symptomatic resolution because the underlying mucosal changes and the chronic iron deficiency exposure history remain. Lifelong surveillance endoscopy every 1–3 years is the standard regardless of symptom status — discontinuing it is a documented pathway to delayed cancer diagnosis.

S5. Clinical Commentary — Differential, Cancer Risk, Referral

Differential Diagnosis

ConditionDistinguishing Features
Postcricoid esophageal cancerMass on imaging or endoscopy; biopsy diagnostic; symptoms progressive rather than chronic intermittent; weight loss; hoarseness
Zenker diverticulumPharyngeal pouch through Killian dehiscence; regurgitation of undigested food, halitosis, audible gurgling; barium swallow shows characteristic outpouching
Schatzki ring (lower esophagus)Distal esophageal mucosal ring at gastroesophageal junction; intermittent solid dysphagia (“steakhouse syndrome”); not associated with iron deficiency
Cricopharyngeal dysfunction / achalasiaFailure of upper esophageal sphincter relaxation; barium swallow with manometry; treated with cricopharyngeal myotomy
Eosinophilic esophagitisAllergic background; eosinophilic infiltrate on biopsy (>15 per HPF); ringed esophagus; proton pump inhibitor and topical steroid responsive
Esophageal motility disorders (DES, jackhammer)Manometry confirms; chest pain and dysphagia overlap
Globus sensationSensation of lump without true dysphagia; normal endoscopy and imaging; stress/anxiety associated
Gastric cancer with iron deficiency (not PVS)Iron deficiency from chronic occult GI bleed; gastric mass on EGD; no esophageal web

Cancer Risk and Modifiers

The 4–16% lifetime esophageal SCC risk in PVS is influenced by several factors that warrant explicit attention:

  • Tobacco use — substantially synergizes risk; cessation is the most modifiable factor
  • Alcohol use — synergistic with both PVS and tobacco; reduction or cessation reduces risk
  • Persistence of iron deficiency — durable iron repletion may reduce cancer risk over time
  • Web persistence — webs that persist on follow-up endoscopy may carry higher risk than those resolved with iron repletion
  • HPV co-infection — relevant for oropharyngeal cancers; testing of suspicious lesions
  • Age — risk increases with age and duration of disease

Referral

When to Engage Specialty Services

  • Gastroenterology: Mandatory for endoscopic diagnosis, web dilation, source workup, and surveillance.
  • Hematology: For iron deficiency management complexity — persistent deficiency despite repletion, intolerance to oral iron, suspected hemoglobinopathies, or unusually severe presentations.
  • ENT (otolaryngology): For laryngoscopy as part of comprehensive upper aerodigestive cancer surveillance; particularly for any voice changes, oral cavity lesions, or pharyngeal symptoms.
  • Surgery (head and neck, thoracic): When esophageal or postcricoid cancer is diagnosed.
  • Dietitian / nutrition: For dietary iron optimization and nutritional rehabilitation.
  • Gynecology: For still-menstruating patients with persistent iron loss.
  • Tobacco cessation counseling: Given the synergistic cancer risk.
  • Genetic counseling: Rarely needed; PVS itself is not strongly inherited but family clustering has been reported.

S6. Practice Insights — Synthesized Patterns for PVS Care

(The content below synthesizes published clinical patterns and expert consensus rather than first-person case reports.) Plummer-Vinson syndrome is the rare disease where the diagnostic recognition is straightforward when the triad is considered — and frequently missed entirely when it is not. Across published series and gastroenterology expert practice, patients commonly carry iron deficiency anemia for years and minimize their dysphagia or modify diet to avoid offending textures, with the postcricoid web missed on multiple endoscopies that did not specifically inspect the cricopharyngeal level. The patients who do best are those whose iron deficiency triggers a focused look at the cervical esophagus during endoscopy, whose dysphagia is taken seriously rather than attributed to globus or anxiety, and whose lifelong cancer surveillance commitment is established at the first visit.

1. Iron Deficiency + Any Dysphagia = Look at the Postcricoid

Across published expert practice, every patient with iron deficiency anemia and any dysphagia — even mild and chronic — warrants careful endoscopic inspection at the cricopharyngeal level on EGD. The web is anatomically just below the upper esophageal sphincter and easy to miss on rapid endoscope passage. Experienced endoscopists pause specifically at the postcricoid region during withdrawal, use lateral angulation, and document explicitly whether the web is present or absent. Cases of “negative endoscopy” in patients who later prove to have PVS often reflect inadequate postcricoid inspection rather than absence of the web.

2. Try Iron First Before Committing to Dilation

Published series and expert practice converge on iron repletion alone resolving dysphagia in a substantial fraction of mild-to-moderate cases as mucosal atrophy reverses over weeks-to-months. The established approach reserves dilation for severely symptomatic patients at presentation, failure of iron repletion at 8–12 weeks, or web persistence on follow-up endoscopy. Combining both is also reasonable. Premature commitment to dilation when iron alone would have sufficed adds procedural risk without benefit.

3. Source Workup Is Not Optional

Iron deficiency in PVS reflects an underlying cause — usually combination of dietary, menstrual, or occult GI bleeding — and addressing that cause is essential to prevent recurrence. The established workup pattern includes bidirectional endoscopy, celiac serology, H. pylori testing, and gynecologic evaluation in still-menstruating women. Treating iron deficiency without source identification produces durable correction in some patients but recurrent deficiency in many.

4. Lifelong Cancer Surveillance Is the Defining Commitment

The 4–16% lifetime esophageal SCC risk persists beyond symptomatic resolution and beyond web disappearance. Published long-term series document cancer development years to decades after initial diagnosis, often after patients have lost touch with gastroenterology. Established practice frames lifelong endoscopic surveillance every 1–3 years as the defining commitment of PVS care at the first diagnostic visit — patients who understand this from the start maintain surveillance better than those who learn about it years later.

Illustrative Scenario — The Postmenopausal Woman with the Long-Standing “Lump in the Throat”

(Composite teaching scenario assembled from published patterns; not an individual patient.)

A patient in their early sixties presented to primary care with fatigue and pallor noted on routine examination. CBC showed microcytic hypochromic anemia (Hgb 9.2 g/dL, MCV 68 fL) with ferritin 8 ng/mL and transferrin saturation 6%. On detailed history the patient endorsed “lump-in-throat sensation” and difficulty swallowing certain foods for “many years” — bread, dry meat, and large pills — which she had managed by drinking water with meals and avoiding offending textures; she had not considered it a medical complaint. Examination showed pale conjunctivae, koilonychia of bilateral fingernails, atrophic glossitis with smooth tongue, and angular cheilitis. EGD with explicit inspection at the postcricoid level on withdrawal demonstrated a thin anterior eccentric mucosal web at the cricopharyngeal level; biopsy of the web and surrounding mucosa showed no dysplasia or malignancy; remaining EGD and colonoscopy were unremarkable for bleeding source; celiac serology was negative; H. pylori was negative; gynecologic evaluation confirmed postmenopausal status without uterine pathology. Diagnosis of Plummer-Vinson syndrome was established. Treatment with oral ferrous sulfate 325 mg twice daily plus vitamin C 250 mg was initiated. Through-the-scope balloon dilation of the web (to 18 mm) was performed during the diagnostic endoscopy. Dysphagia resolved within 2 weeks of dilation; hemoglobin normalized by week 12; ferritin reached 145 ng/mL by month 6. The patient was counseled about lifelong endoscopic surveillance every 2 years given the elevated esophageal SCC risk, with tobacco and alcohol abstinence reinforced. Surveillance endoscopy at 12 months and 24 months showed no web recurrence and no concerning mucosal changes.

Takeaway: Iron deficiency anemia plus long-standing minimized dysphagia in a postmenopausal woman should trigger explicit postcricoid endoscopic inspection. Combined iron repletion plus dilation provides rapid relief; source workup prevents recurrence; lifelong endoscopic surveillance is the durable commitment.

Practice Pattern Refinements Beyond the Standard Guideline

  1. Every patient with iron deficiency anemia and any dysphagia (even chronic and minimized) warrants explicit postcricoid endoscopic inspection on EGD — the web is anatomically easy to miss on rapid passage; experienced endoscopists pause at the cricopharyngeal level during withdrawal and document its presence or absence.
  2. A trial of iron repletion alone (8–12 weeks) is reasonable before committing to dilation for mild-to-moderate dysphagia — many patients have dysphagia resolution as mucosal atrophy reverses; dilation is reserved for severe symptoms, treatment failure, or web persistence on follow-up.
  3. Iron deficiency source workup (bidirectional endoscopy, celiac serology, H. pylori, gynecologic evaluation) is mandatory at PVS diagnosis — treating the deficiency without addressing the cause produces recurrent deficiency in many patients.
  4. Lifelong endoscopic surveillance every 1–3 years is framed as the defining commitment of PVS care at the first visit — the 4–16% esophageal SCC risk persists beyond symptomatic resolution and beyond web disappearance; patients who understand this from the start maintain surveillance better.

S7. Frequently Asked Questions

Q: What is the classic Plummer-Vinson triad?
The classic triad consists of iron deficiency anemia, dysphagia, and cervical (postcricoid) esophageal web. The syndrome is also called Paterson-Brown-Kelly syndrome in the British literature and sideropenic dysphagia in some references. Classic stigmata of iron deficiency including koilonychia, atrophic glossitis, angular cheilitis, and pallor complete the clinical picture.
Q: Why does Plummer-Vinson syndrome occur predominantly in postmenopausal women?
The disease’s striking predilection for postmenopausal women reflects converging factors: prolonged menstrual iron loss over reproductive years producing cumulative iron deficit, historical dietary iron insufficiency (particularly in northern European populations where the disease was first described), pregnancy-related iron depletion in multiparous women, and the time required for chronic iron deficiency to produce trophic mucosal changes. Female-to-male ratio is approximately 5:1.
Q: How is the cervical esophageal web diagnosed?
Barium swallow with attention to the cervical esophagus shows a thin shelf-like filling defect at the postcricoid level, typically anterior and eccentric. Endoscopy with explicit inspection at the cricopharyngeal level during withdrawal directly visualizes the web — careful technique is required because the web is just below the upper esophageal sphincter and easily missed on rapid endoscope passage. Biopsy of the web and surrounding mucosa is performed to exclude malignancy given the elevated cancer risk.
Q: What is the first-line treatment?
Iron repletion is the foundational therapy — oral ferrous sulfate 325 mg daily-to-TID with vitamin C for absorption, or IV iron when oral intolerance or malabsorption is present. Hematologic correction frequently produces resolution of dysphagia within weeks-to-months as mucosal atrophy reverses. Endoscopic web dilation (through-the-scope balloon or Savary-Gilliard bougie) is added for severe symptoms at presentation, failure of iron repletion at 8–12 weeks, or web persistence on follow-up endoscopy.
Q: What is the esophageal cancer risk in Plummer-Vinson syndrome?
Lifetime risk of squamous cell carcinoma of the postcricoid esophagus, hypopharynx, and oral cavity is estimated at 4–16% in PVS — an order of magnitude above the general population baseline of approximately 0.5%. This elevated risk is the rationale for lifelong endoscopic surveillance every 1–3 years even after symptomatic resolution. Tobacco and alcohol substantially synergize the risk and warrant cessation counseling at every visit.
Q: Should iron deficiency source workup be performed in PVS patients?
Yes, mandatorily. Iron deficiency in PVS reflects an underlying cause — typically a combination of dietary, menstrual, and occult GI bleeding contributors. The source workup includes bidirectional endoscopy (EGD plus colonoscopy) for bleeding sources, celiac serology for malabsorption, H. pylori testing, and gynecologic evaluation in still-menstruating women. Treating iron deficiency without identifying the cause produces recurrent deficiency in many patients.
Q: How long does iron repletion need to continue?
Iron repletion continues for at least 6 months after hemoglobin normalization to replenish stores, with ferritin target greater than 50 ng/mL (ideally greater than 100 ng/mL). Maintenance iron supplementation may be indicated indefinitely if the underlying cause of iron deficiency persists (ongoing menstrual loss, malabsorption from celiac disease, post-bariatric surgery, dietary restriction). Annual monitoring of CBC and ferritin guides ongoing repletion needs.
Q: How often should cancer surveillance endoscopy be performed?
Endoscopy every 1–3 years indefinitely, depending on individual risk factors including web persistence, tobacco/alcohol use, prior dysplastic changes, and age. Surveillance includes careful inspection of the postcricoid region, hypopharynx, and oral cavity with biopsy of any suspicious lesion. ENT laryngoscopy is considered periodically. Tobacco and alcohol cessation counseling occurs at every surveillance visit. The cancer risk persists beyond symptomatic resolution and beyond web disappearance, so surveillance does not have an end date.
↑

Leave a Reply

Your email address will not be published. Required fields are marked *